|
|
0 1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Æ Ø Å
Ønsker du salgsvekst?
B2B Connect er en plattform hvor bedrifter som trenger salgsmøter kan benytte seg av så mange profesjonelle møtebookere de ønsker, fra en stor pool.
Du betaler kun per booket (og gjennomført) salgsmøte, og pris per salgsmøte bestemmer du selv. Det er ingen bindinger, og ingen oppstarts- eller abonnementsavgift. Prøve oss med kun 3 møter?
| Navn | Espen Johnsen |
|---|---|
| Orgnr/født år | 1962 |
| Navn | Ant aksjer | Andel | Omsetning* | Driftsresultat* | Egenkapital* | Ant.eiere |
|---|---|---|---|---|---|---|
| Tave Invest AS | 5,051 | 50.1% | 1,058 | 589 | 9,180 | 4 |
| Tave Invest AS | 2,005 | 19.9% | 420 | 234 | 3,644 | 4 |
* Justert for eierandel
| Navn | Ant aksjer | Andel | Omsetning* | Driftsresultat* | Egenkapital* | Ant.eiere |
|---|---|---|---|---|---|---|
| Refa Brygge AS
Via Tave Invest AS |
3,063,499 | 30.1% | 4,071 | 1,870 | 16,495 | 4 |
| Refa Brygge AS
Via Tave Invest AS |
1,216,059 | 12.0% | 1,616 | 742 | 6,548 | 4 |
| Eli AS
Via Tave Invest AS |
2,253 | 1.4% | -1 | 41 | 5 | |
| Eli AS
Via Tave Invest AS |
894 | 0.6% | -1 | 16 | 5 | |
| Pharma Holdings AS
Via Tave Invest AS |
4,563 | 0.5% | 8 | -68 | 74 | 291 |
| Lytix Biopharma AS
Via Tave Invest AS |
78,415 | 0.2% | 8 | -189 | 100 | 1,097 |
| Pharma Holdings AS
Via Tave Invest AS |
1,811 | 0.2% | 3 | -27 | 29 | 291 |
| Pharmasum Therapeutics AS
Via Tave Invest AS |
2,814 | 0.1% | 1 | -1 | 2 | 683 |
| Lytix Biopharma AS
Via Tave Invest AS |
31,127 | 0.1% | 3 | -75 | 40 | 1,097 |
| Amicoat AS
Via Tave Invest AS |
19,856 | 0.1% | 12 | -3 | 37 | 311 |
| Pharmasum Therapeutics AS
Via Tave Invest AS |
1,117 | 0.0% | 0 | -1 | 1 | 683 |
| Amicoat AS
Via Tave Invest AS |
7,882 | 0.0% | 5 | -1 | 14 | 311 |
* Justert for eierandel
